First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Shaw, Alice T, Bauer, Todd M, de Marinis, Filippo, Felip, Enriqueta, Goto, Yasushi, Liu, Geoffrey, Mazieres, Julien, Kim, Dong-Wan, Mok, Tony, Polli, Anna, Thurm, Holger, Calella, Anna M, Peltz, Gerson, Solomon, Benjamin J
Published in The New England journal of medicine (19.11.2020)
Published in The New England journal of medicine (19.11.2020)
Get full text
Journal Article
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Mazieres, Julien, Iadeluca, Laura, Shaw, Alice T., Solomon, Benjamin J., Bauer, Todd M., de Marinis, Filippo, Felip, Enriqueta, Goto, Yasushi, Kim, Dong-Wan, Mok, Tony, Reisman, Arlene, Thurm, Holger, Polli, Anna M., Liu, Geoffrey
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2022)
Get full text
Journal Article
Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer
LØNNING, Per E, GEISLER, Jürgen, POLLI, Anna, MASSIMINI, Giorgio, KRAG, Lars E, ERIKSTEIN, Bjørn, BREMNES, Yngve, HAGEN, Anne I, SCHLICHTING, Ellen, LIEN, Ernst A, ØFJORD, Erik S, PAOLINI, Jolanda
Published in Journal of clinical oncology (01.08.2005)
Published in Journal of clinical oncology (01.08.2005)
Get full text
Journal Article
Conference Proceeding
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC
Zhou, Qing, Soo, Ross A., Chang, Gee-Chen, Chiu, Chao-Hua, Hayashi, Hidetoshi, Kim, Sang-We, Teraoka, Shunsuke, Goto, Yasushi, Zhou, Jianying, Ho-Fun Lee, Victor, Kim, Dong-Wan, Han, Baohui, Chung Man Ho, James, Lin, Chia-Chi, Lu, Shun, Polli, Anna, Calella, Anna Maria, Martini, Jean-François, Wong, Chew Hooi, Mok, Tony, Kim, Hye Ryun, Wu, Yi-Long
Published in JTO clinical and research reports (01.05.2023)
Published in JTO clinical and research reports (01.05.2023)
Get full text
Journal Article
Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial
KAUFMANN, M, BAJETTA, E, FOWST, C, POLLI, A, DI SALLE, E, ARKHIPOV, A, PISCITELLI, G, MILLER, L. L, MASSIMINI, G, DIRIX, L. Y, FEIN, L. E, JONES, S. E, ZILEMBO, N, DUGARDYN, J.-L, NASURDI, C, MENNEL, R. G, CERVEK, J
Published in Journal of clinical oncology (07.04.2000)
Published in Journal of clinical oncology (07.04.2000)
Get full text
Journal Article
Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
Lønning, P E, Bajetta, E, Murray, R, Tubiana-Hulin, M, Eisenberg, P D, Mickiewicz, E, Celio, L, Pitt, P, Mita, M, Aaronson, N K, Fowst, C, Arkhipov, A, di Salle, E, Polli, A, Massimini, G
Published in Journal of clinical oncology (11.06.2000)
Published in Journal of clinical oncology (11.06.2000)
Get full text
Journal Article
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
Webster, Jonathan, Piscitelli, Gabriella, Polli, Anna, Ferrari, Carlo I, Ismail, Ikram, Scanlon, Maurice F
Published in The New England journal of medicine (06.10.1994)
Published in The New England journal of medicine (06.10.1994)
Get full text
Journal Article
Web Resource
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)
Ou, Sai-Hong, Kilvert, Hannah, Candlish, Jane, Lee, Ben, Polli, Anna, Thomaidou, Despina, Le, Hannah
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2024)
Get full text
Journal Article
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Costa, Daniel B, Shaw, Alice T, Ou, Sai-Hong I, Solomon, Benjamin J, Riely, Gregory J, Ahn, Myung-Ju, Zhou, Caicun, Shreeve, S Martin, Selaru, Paulina, Polli, Anna, Schnell, Patrick, Wilner, Keith D, Wiltshire, Robin, Camidge, D Ross, Crinò, Lucio
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK -Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study
Solomon, Benjamin J, Bauer, Todd M, Ignatius Ou, Sai-Hong, Liu, Geoffrey, Hayashi, Hidetoshi, Bearz, Alessandra, Penkov, Konstantin, Wu, Yi-Long, Arrieta, Oscar, Jassem, Jacek, Calella, Anna M, Peltz, Gerson, Polli, Anna, Thurm, Holger, Mok, Tony
Published in Journal of clinical oncology (01.11.2022)
Published in Journal of clinical oncology (01.11.2022)
Get full text
Journal Article
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
Solomon, Benjamin J, Bauer, Todd M, Mok, Tony S K, Liu, Geoffrey, Mazieres, Julien, de Marinis, Filippo, Goto, Yasushi, Kim, Dong-Wan, Wu, Yi-Long, Jassem, Jacek, López, Froylán López, Soo, Ross A, Shaw, Alice T, Polli, Anna, Messina, Rossella, Iadeluca, Laura, Toffalorio, Francesca, Felip, Enriqueta
Published in The lancet respiratory medicine (01.04.2023)
Published in The lancet respiratory medicine (01.04.2023)
Get more information
Journal Article
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Shaw, Alice T, Kim, Dong-Wan, Nakagawa, Kazuhiko, Seto, Takashi, Crinó, Lucio, Ahn, Myung-Ju, De Pas, Tommaso, Besse, Benjamin, Solomon, Benjamin J, Blackhall, Fiona, Wu, Yi-Long, Thomas, Michael, O'Byrne, Kenneth J, Moro-Sibilot, Denis, Camidge, D. Ross, Mok, Tony, Hirsh, Vera, Riely, Gregory J, Iyer, Shrividya, Tassell, Vanessa, Polli, Anna, Wilner, Keith D, Jänne, Pasi A
Published in The New England journal of medicine (20.06.2013)
Published in The New England journal of medicine (20.06.2013)
Get full text
Journal Article
Management of patients with ALK -positive advanced non-small cell lung cancer who received brain radiotherapy on study in the phase 3 CROWN trial
Bauer, Todd Michael, Felip, Enriqueta, Mok, Tony S. K., Wu, Yi-Long, Liu, Geoffrey, Goto, Yasushi, Kim, Dong-Wan, Paolini, Jolanda, Polli, Anna, Solomon, Benjamin J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect Comparisons
Garcia, Christine, Abrahami, Devin, Polli, Anna, Chu, Haitao, Chandler, Conor, Tan, Min, Kelton, John Mark, Thomaidou, Despina, Bauer, Todd
Published in Clinical lung cancer (01.11.2024)
Published in Clinical lung cancer (01.11.2024)
Get full text
Journal Article
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study
Dudnichenko, Oleksandr, Penkov, Konstantin, McKean, Meredith, Mandalà, Mario, Kukushkina, Mariia, Panella, Timothy, Csőszi, Tibor, Gerletti, Paola, Thakur, Mahgull, Polli, Anna, di Pietro, Alessandra, Schadendorf, Dirk
Published in European journal of cancer (1990) (01.12.2024)
Published in European journal of cancer (1990) (01.12.2024)
Get full text
Journal Article
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
Solomon, Benjamin J, Liu, Geoffrey, Felip, Enriqueta, Mok, Tony S K, Soo, Ross A, Mazieres, Julien, Shaw, Alice T, de Marinis, Filippo, Goto, Yasushi, Wu, Yi-Long, Kim, Dong-Wan, Martini, Jean-François, Messina, Rossella, Paolini, Jolanda, Polli, Anna, Thomaidou, Despina, Toffalorio, Francesca, Bauer, Todd M
Published in Journal of clinical oncology (10.10.2024)
Published in Journal of clinical oncology (10.10.2024)
Get full text
Journal Article
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer with ALK Translocation
Patel, Sandip Pravin, Pakkala, Suchita, Pennell, Nathan A., Reckamp, Karen L., Lanzalone, Silvana, Polli, Anna, Tarazi, Jamal, Robert‐Vizcarrondo, Francisco
Published in The oncologist (Dayton, Ohio) (01.07.2020)
Published in The oncologist (Dayton, Ohio) (01.07.2020)
Get full text
Journal Article
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
Bearz, Alessandra, Martini, Jean-François, Jassem, Jacek, Kim, Sang-We, Chang, Gee-Chen, Shaw, Alice T., Shepard, Deborah A., Dall’O’, Elisa, Polli, Anna, Thurm, Holger, Zalcman, Gerard, Garcia Campelo, Maria Rosario, Penkov, Konstantin, Hayashi, Hidetoshi, Solomon, Benjamin J.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
Encorafenib (enco) + binimetinib (bini) + pembrolizumab (pembro) for unresectable locally advanced or metastatic BRAF V600-mutant melanoma: Results from STARBOARD safety lead-in (SLI)
Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Ribas, Antoni, Sullivan, Ryan J., Panella, Timothy J., McKean, Meredith, Santos, Edgardo S., Clancy, Jill S., Thakur, Mahgull Nazar, Polli, Anna, Di Pietro, Alessandra, Ascierto, Paolo Antonio
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article